US Stock MarketDetailed Quotes

SLRX Salarius Pharmaceuticals

Watchlist

0.4632
+0.0017+0.37%

Close May 31 16:00 ET

2.21MMarket Cap-229P/E (TTM)

Salarius Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-67.32%1.77M

-43.87%12.89M

-85.02%970.7K

-54.96%2.53M

-16.53%3.97M

-11.39%5.42M

79.31%22.98M

181.08%6.48M

50.06%5.62M

29.00%4.76M

Selling and administrative expenses

-9.82%1.53M

-19.85%5.72M

-49.18%910.75K

-18.35%1.5M

-11.81%1.62M

1.03%1.7M

16.93%7.14M

23.67%1.79M

5.85%1.83M

15.36%1.84M

-General and administrative expense

-9.82%1.53M

-19.85%5.72M

-49.18%910.75K

-18.35%1.5M

-11.81%1.62M

1.03%1.7M

16.93%7.14M

23.67%1.79M

5.85%1.83M

15.36%1.84M

Research and development costs

-93.48%243K

-54.70%7.17M

-98.72%59.95K

-72.66%1.04M

-19.50%2.35M

-16.08%3.73M

85.26%15.84M

73.82%4.69M

88.01%3.79M

39.37%2.92M

Operating profit

67.32%-1.77M

43.87%-12.89M

85.02%-970.7K

54.96%-2.53M

16.53%-3.97M

11.39%-5.42M

-79.31%-22.98M

-56.29%-6.48M

-50.06%-5.62M

-52.65%-4.76M

Net non-operating interest income expense

-29.50%56.33K

61.04%352.25K

-3.88%88.91K

13.69%89.37K

137.42%94.09K

898.13%79.89K

218.73K

92.49K

16,041.07%78.61K

14,854.34%39.63K

Non-operating interest income

-29.50%56.33K

61.04%352.25K

-3.88%88.91K

13.69%89.37K

----

898.13%79.89K

--218.73K

--92.49K

--78.61K

----

Total other finance cost

----

-137.42%-94.09K

----

-14,854.34%-39.63K

Other net income (expense)

-19,905.01%-8.85M

-63.40%14.45K

-97,817.50%-8.87M

Gain on sale of security

----

-67.66%14.45K

----

Special income (charges)

----

--0

----

---8.87M

--0

---8.87M

----

-Less:Impairment of capital assets

----

--0

----

--8.87M

--0

--8.87M

----

Income before tax

67.88%-1.72M

60.32%-12.54M

86.16%-881.8K

83.05%-2.44M

17.82%-3.88M

12.58%-5.34M

-147.55%-31.61M

-55.20%-6.37M

-285.58%-14.41M

-53.47%-4.72M

Income tax

Net income

67.88%-1.72M

60.32%-12.54M

86.16%-881.8K

83.05%-2.44M

17.82%-3.88M

12.58%-5.34M

-147.55%-31.61M

-55.20%-6.37M

-285.58%-14.41M

-53.47%-4.72M

Net income continuous Operations

67.88%-1.72M

60.32%-12.54M

86.16%-881.8K

83.05%-2.44M

17.82%-3.88M

12.58%-5.34M

-147.55%-31.61M

-55.20%-6.37M

-285.58%-14.41M

-53.47%-4.72M

Minority interest income

Net income attributable to the parent company

67.88%-1.72M

60.32%-12.54M

86.16%-881.8K

83.05%-2.44M

17.82%-3.88M

12.58%-5.34M

-147.55%-31.61M

-55.20%-6.37M

-285.58%-14.41M

-53.47%-4.72M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

67.88%-1.72M

60.32%-12.54M

86.16%-881.8K

83.05%-2.44M

17.82%-3.88M

12.58%-5.34M

-147.55%-31.61M

-55.20%-6.37M

-285.58%-14.41M

-53.47%-4.72M

Basic earnings per share

81.61%-0.41

74.19%-3.84

89.86%-0.65

35.00%-1.43

32.42%-2.23

-92.75%-14.88

-22.22%-2.75

-206.70%-6.41

-25.71%-2.2

Diluted earnings per share

81.61%-0.41

74.19%-3.84

89.86%-0.65

35.00%-1.43

32.42%-2.23

-92.75%-14.88

-22.22%-2.75

-206.70%-6.41

-25.71%-2.2

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-67.32%1.77M	-43.87%12.89M	-85.02%970.7K	-54.96%2.53M	-16.53%3.97M	-11.39%5.42M	79.31%22.98M	181.08%6.48M	50.06%5.62M	29.00%4.76M
Selling and administrative expenses	-9.82%1.53M	-19.85%5.72M	-49.18%910.75K	-18.35%1.5M	-11.81%1.62M	1.03%1.7M	16.93%7.14M	23.67%1.79M	5.85%1.83M	15.36%1.84M
-General and administrative expense	-9.82%1.53M	-19.85%5.72M	-49.18%910.75K	-18.35%1.5M	-11.81%1.62M	1.03%1.7M	16.93%7.14M	23.67%1.79M	5.85%1.83M	15.36%1.84M
Research and development costs	-93.48%243K	-54.70%7.17M	-98.72%59.95K	-72.66%1.04M	-19.50%2.35M	-16.08%3.73M	85.26%15.84M	73.82%4.69M	88.01%3.79M	39.37%2.92M
Operating profit	67.32%-1.77M	43.87%-12.89M	85.02%-970.7K	54.96%-2.53M	16.53%-3.97M	11.39%-5.42M	-79.31%-22.98M	-56.29%-6.48M	-50.06%-5.62M	-52.65%-4.76M
Net non-operating interest income expense	-29.50%56.33K	61.04%352.25K	-3.88%88.91K	13.69%89.37K	137.42%94.09K	898.13%79.89K	218.73K	92.49K	16,041.07%78.61K	14,854.34%39.63K
Non-operating interest income	-29.50%56.33K	61.04%352.25K	-3.88%88.91K	13.69%89.37K	----	898.13%79.89K	--218.73K	--92.49K	--78.61K	----
Total other finance cost	----	----	----	----	-137.42%-94.09K	----	----	----	----	-14,854.34%-39.63K
Other net income (expense)							-19,905.01%-8.85M	-63.40%14.45K	-97,817.50%-8.87M
Gain on sale of security	----	----	----	----	----	----	-67.66%14.45K	----	----	----
Special income (charges)	----	--0	--0	--0	----	----	---8.87M	--0	---8.87M	----
-Less:Impairment of capital assets	----	--0	--0	--0	----	----	--8.87M	--0	--8.87M	----
Income before tax	67.88%-1.72M	60.32%-12.54M	86.16%-881.8K	83.05%-2.44M	17.82%-3.88M	12.58%-5.34M	-147.55%-31.61M	-55.20%-6.37M	-285.58%-14.41M	-53.47%-4.72M
Income tax
Net income	67.88%-1.72M	60.32%-12.54M	86.16%-881.8K	83.05%-2.44M	17.82%-3.88M	12.58%-5.34M	-147.55%-31.61M	-55.20%-6.37M	-285.58%-14.41M	-53.47%-4.72M
Net income continuous Operations	67.88%-1.72M	60.32%-12.54M	86.16%-881.8K	83.05%-2.44M	17.82%-3.88M	12.58%-5.34M	-147.55%-31.61M	-55.20%-6.37M	-285.58%-14.41M	-53.47%-4.72M
Minority interest income
Net income attributable to the parent company	67.88%-1.72M	60.32%-12.54M	86.16%-881.8K	83.05%-2.44M	17.82%-3.88M	12.58%-5.34M	-147.55%-31.61M	-55.20%-6.37M	-285.58%-14.41M	-53.47%-4.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	67.88%-1.72M	60.32%-12.54M	86.16%-881.8K	83.05%-2.44M	17.82%-3.88M	12.58%-5.34M	-147.55%-31.61M	-55.20%-6.37M	-285.58%-14.41M	-53.47%-4.72M
Basic earnings per share	81.61%-0.41	74.19%-3.84	0	89.86%-0.65	35.00%-1.43	32.42%-2.23	-92.75%-14.88	-22.22%-2.75	-206.70%-6.41	-25.71%-2.2
Diluted earnings per share	81.61%-0.41	74.19%-3.84	0	89.86%-0.65	35.00%-1.43	32.42%-2.23	-92.75%-14.88	-22.22%-2.75	-206.70%-6.41	-25.71%-2.2
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall